Dr. Walter is currently a Professor in the Translational Science and Therapeutics Division at the Fred Hutchinson Cancer Center, a Professor of Medicine in the Division of Hematology and Oncology/Department of Medicine at the University of Washington (UW), and an Adjunct Professor in the Department of Laboratory Medicine and Pathology at the UW. His research is focused on acute myeloid leukemia (AML), particularly on the improvement of antibody-based therapies via optimizing the efficacy/safety profile of existing therapeutics and through the preclinical and early clinical development of novel antigen-directed immunotherapies. In clinical studies, Dr. Walter conducts trials testing novel treatments and innovative care approaches for AML patients. Furthermore, in collaborative research, he uses large patient datasets to develop and improve diagnostic and prognostic tools for people with AML.